BioSuite AI PortfolioVirtualBio LabOligoLab
OligoLab: Explore the logic behind assay design. Inspect primer and probe design concepts in an educational workspace. Research demo.
OligoLabInspect primer and probe design concepts in an educational workspace.Explore the logic behind assay design. · Research demo
PREM KUMARSCIENCE · LEADERSHIP · AI
← Prem Kumar PerumalOligoLab DEMO VERSIONGuidance & methods ↓

SEQUENCE → CANDIDATES → REVIEW → EXPORT

Design with evidence.
Review before ordering.

A sequence-based primer and hydrolysis probe workbench for research assay development.

Works from supplied unambiguous DNA, not a microorganism-name lookup. No universal coverage or diagnostic validation is claimed. Database-wide specificity, thermodynamic structure checks and experimental validation remain separate review steps.

01 / DEFINE THE TARGET

Start with a reference sequence.

Tm estimates use a monovalent-only nearest-neighbour model. No Mg²⁺, dNTP, dye, MGB or LNA correction. Recheck under the actual assay chemistry.

Files stay in your browser. Plain text only; maximum 150 KB. No archives, PDFs or executable files.

Design filters and search limits

Primers: 18–24 nt, 40–60% GC, estimated Tm 55–65°C, pair ΔTm <3°C. Internal probe: 20–30 nt, 35–65% GC, no 5′ G, estimated Tm 5–10°C above the higher primer Tm. Runs longer than four identical bases are excluded. Probe sites do not overlap primer sites.

Bounded heuristic search: up to 220 forward and 220 reverse candidates; probe search in the best 150 preliminary pairs; up to 10 distinct amplicon boundaries. A zero-result search does not establish that no suitable assay exists. No degenerate bases, transcript/exon design, multiplex optimisation or genome retrieval is implemented.

02 / LOCAL BIOINFORMATICS

Inspect the candidates.

Generate candidates to see coordinates, sequences and design metrics.

Optional comparison FASTA panel

Paste intended target variants or non-target sequences. This check counts exact oligo matches on both strands only; it does not align genomes, tolerate mismatches, predict off-target amplicons or establish inclusivity/exclusivity.

03 / DOCUMENT THE DECISION

Build a reviewable order worksheet.

Export a draft at any time. A reviewer-attested worksheet requires all checklist items, reviewer name, reference metadata and evidence notes. A checkbox records a human attestation—it does not run the external check.

These are worksheet fields, not recommendations. Reporter/quencher pairing, instrument channels, blocking and purification must be confirmed with the supplier. Plain sequences are 5′→3′; modifications are separate columns.

Draft · review incomplete.

Generic CSV worksheet, not an automatic supplier order or guaranteed bulk-import format. Confirm all fields with your supplier. Exports remain research candidates; reviewer attestation is not assay validation.

04 / GUIDANCE REVIEWED · 2 NOVEMBER 2026

Methods and evidence.

MIQE 2.0 · 2025

The revised research reporting guidelines cover assay design, sequence identification, specificity, controls and performance validation. This checklist supports documentation; it is not MIQE certification or regulatory approval.

Read MIQE 2.0 ↗

Specificity · NCBI Primer-BLAST

Use an appropriate template accession and database search scope. Record databases, organism filters, settings and date. This app does not submit sequences to NCBI or claim that a BLAST search has run.

Open Primer-BLAST ↗

Tm and structural review

OligoLab 1.0 implements SantaLucia-style DNA nearest-neighbour estimates with monovalent salt correction (1–500 mM) and specified strand concentration. Self-complementary sequences receive a symmetry correction. It does not run Primer3. Contiguous complement lengths are simple flags, not ΔG calculations or hairpin predictions.

Primer3 methods and parameters ↗ · IDT OligoAnalyzer ↗

Hydrolysis probe considerations

Probe Tm relative to primers, 5′ base identity and chemistry need review. Rules are starting points and must be tailored to the application.

IDT primer and probe design guidance ↗

Guidance snapshot, not a live guideline feed. A qualified scientist must assess current requirements for the intended application. RNA assays require additional reverse-transcription design and validation. No clinical result interpretation is implemented.